Related Experiment Video
Updated: May 3, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
GRK3 is essential for metastatic cells and promotes prostate tumor progression
Wenliang Li1, Nanping Ai, Suming Wang
1Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030.
Abstract:
The biochemical mechanisms that regulate the process of cancer metastasis are still poorly understood. Because kinases, and the signaling pathways they comprise, play key roles in regulation of many cellular processes, we used an unbiased RNAi in vitro screen and a focused cDNA in vivo screen against human kinases to identify those with previously undocumented roles in metastasis. We discovered that G-protein-coupled receptor kinase 3 (GRK3; or β-adrenergic receptor kinase 2) was not only necessary for survival and proliferation of metastatic cells, but also sufficient to promote primary prostate tumor growth and metastasis upon exogenous expression in poorly metastatic cells in mouse xenograft models. Mechanistically, we found that GRK3 stimulated angiogenesis, at least in part through down-regulation of thrombospondin-1 and plasminogen activator inhibitor type 2. Furthermore, GRK3 was found to be overexpressed in human prostate cancers, especially in metastatic tumors. Taken together, these data suggest that GRK3 plays an important role in prostate cancer progression and metastasis.
Insights
G-protein-coupled receptor kinase 3 (GRK3) drives prostate cancer growth and metastasis by promoting angiogenesis. This kinase is overexpressed in human prostate tumors, highlighting its role in cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer metastasis mechanisms remain incompletely understood.
- Kinases and their signaling pathways are crucial regulators of cellular processes.
- Identifying novel regulators of metastasis is critical for therapeutic development.
Purpose of the Study:
- To identify human kinases with previously undocumented roles in cancer metastasis.
- To investigate the specific role of G-protein-coupled receptor kinase 3 (GRK3) in prostate cancer progression.
Main Methods:
- Unbiased RNA interference (RNAi) in vitro screen against human kinases.
- Focused complementary DNA (cDNA) in vivo screen against human kinases.
- Mouse xenograft models to assess GRK3's effect on tumor growth and metastasis.
- Analysis of GRK3 expression in human prostate cancer tissues.
Main Results:
- GRK3 is essential for the survival and proliferation of metastatic cells.
- Exogenous GRK3 expression promotes primary prostate tumor growth and metastasis in vivo.
- GRK3 stimulates angiogenesis, partly via down-regulation of thrombospondin-1 and plasminogen activator inhibitor type 2.
- GRK3 is overexpressed in human prostate cancers, particularly in metastatic tumors.
Conclusions:
- GRK3 plays a significant role in prostate cancer progression and metastasis.
- GRK3's pro-angiogenic activity contributes to its metastatic potential.
- GRK3 represents a potential therapeutic target for advanced prostate cancer.
Related Concept Videos
Mitogens and the Cell Cycle
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

